This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Day Ahead: Welcome to Your Personal 'Gut Check'

Listen. There was a "key reversal" in the S&P 500 last Tuesday -- the market jumped at the open to a new high, and then closed below the prior day's lows -- as was duly noted in Barron's, as well as in this column. That should have set off all kinds of inner alarm bells, and it should have confirmed more than a handful of negative recent macroeconomic signals that had gotten lost in the wave of bullishness. Since I believe you overlooked the meaning of that "key reversal," and since the fear there is this indecision on the next course of action, here is your gut check.

The Fed: I am starting to believe we'll see a muted to negative reaction in stocks not only if Bernanke and company reluctantly holding the line on a new round of quantitative easing, but also if the Fed acts at all. For real, $250 billion in additional bond buys will be disappointing, as it will massively let down the bulls and support the view that the Fed is running dry of actions to energize the recovery. Gut check: A lose/lose scenario is taking shape around an event that, weeks earlier, had only been seen as über-positive.

The European Union: When you buy a stock today, you are essentially pledging faith that EU politicians will act in September in a manner that keeps "euro debt risk flare" at bay, as this was a key driver of the rally. Overall, that is too much faith for my liking, and especially as the ECB gears up to convene Sept. 6 -- a meeting in which the central bank is likely to delay bond purchases, which would then undermine ECB President Mario Draghi's recent rhetoric. A German vote on the EU bailout fund is scheduled to follow that meeting, as well. These people deserve none of your faith -- case closed. It's a lose/lose scenario on the horizon.

The "China Syndrome" is rampant: I have coined a new finance term, and it's called "China Syndrome." Do you have it? Dr. Soz diagnoses it as a perpetual belief that China is always waiting in the wings with an interest-rate cut and that, should it act with one, this action will immediately reverse many increasingly worrying signs on the ground. Riddle me this: Would an interest-rate cut in the next one to three months reverse a downtrend in unit prices at Tiffany (TIF - Get Report) in China due to a shift in how the Chinese are consuming? Or would it be super helpful toward cleaning up excess inventories of Nike (NKE - Get Report) sneakers and of steel? I'd say "nope" on both accounts.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 15,973.56 +313.38 2.00%
S&P 500 1,863.10 +34.02 1.86%
NASDAQ 4,335.5170 +68.68 1.61%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs